Cargando…
Development of a Stromal Microenvironment Experimental Model Containing Proto-Myofibroblast Like Cells and Analysis of Its Crosstalk with Melanoma Cells: A New Tool to Potentiate and Stabilize Tumor Suppressor Phenotype of Dermal Myofibroblasts
Melanoma is one of the most aggressive solid tumors and includes a stromal microenvironment that regulates cancer growth and progression. The components of stromal microenvironment such as fibroblasts, fibroblast aggregates and cancer-associated fibroblasts (CAFs) can differently influence the melan...
Autores principales: | Avagliano, Angelica, Ruocco, Maria Rosaria, Nasso, Rosarita, Aliotta, Federica, Sanità, Gennaro, Iaccarino, Antonino, Bellevicine, Claudio, Calì, Gaetano, Fiume, Giuseppe, Masone, Stefania, Masullo, Mariorosario, Montagnani, Stefania, Arcucci, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912587/ https://www.ncbi.nlm.nih.gov/pubmed/31739477 http://dx.doi.org/10.3390/cells8111435 |
Ejemplares similares
-
Generation and analysis of spheroids from human primary skin myofibroblasts: an experimental system to study myofibroblasts deactivation
por: Granato, Giuseppina, et al.
Publicado: (2017) -
Metabolic Plasticity of Melanoma Cells and Their Crosstalk With Tumor Microenvironment
por: Avagliano, Angelica, et al.
Publicado: (2020) -
Inhibition mechanism of naphthylphenylamine derivatives acting on the CDC25B dual phosphatase and analysis of the molecular processes involved in the high cytotoxicity exerted by one selected derivative in melanoma cells
por: Aliotta, Federica, et al.
Publicado: (2020) -
Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape
por: Romano, Veronica, et al.
Publicado: (2021) -
Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity
por: Avagliano, Angelica, et al.
Publicado: (2019)